Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Tilray Brands

Tilray Brands Stock Is Climbing Monday: What's Driving The Action?

Shares of Tilray Brands Inc (NASDAQ:TLRY) are trading higher Monday morning, building on a recent rally fueled by heavy trading volume and company announcements. The cannabis giant’s stock has been a focal point for investors in recent sessions, driven by a combination of high short interest and positive industry news.

Benzinga

What's Going On With Tilray Brands Stock?

Shares of Tilray Brands Inc (NASDAQ:TLRY) are surging higher Wednesday, extending a recent rally on heavy trading volume. Here’s what investors need to know.

Benzinga

Tilray (TLRY) Stock Surges On Heavy Volume: What Investors Should Know

Shares of Tilray Brands Inc (NASDAQ:TLRY) are trading sharply higher Tuesday afternoon, continuing a recent trend of investor interest across social media despite a lack of company-specific news for the session. Here’s what investors need to know.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

What's Going On With Tilray Brands Stock Today?

Tilray Brands Inc (NASDAQ:TLRY) stock is trending across social media Thursday, despite a lack of fresh company-specific news for the session. The cannabis and consumer brands company made several strategic moves in June that could be fueling the current interest.

Benzinga

Is Tilray Stock a Buy on Positive Cannabis Data?

Tilray reported a positive update for its chemo-related drug.

Barchart

1 Cannabis Stock I Would Buy, and One I Would Avoid

The cannabis industry is rapidly growing, but will Canadian players be able to keep up?

Barchart

2 Growth Stocks With 32% to 77% Upside in 2024

While AI stocks are the center of attention right now, many other growth stocks in various industries are going unnoticed. These stocks may benefit investors in the long run.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Is Tilray Brands (TLRY) a Possible Buy Opportunity Before Earnings?

Tilray Brands (TLRY) holds the leadership position in the cannabis market of Canada. Additionally, it is making forays into the beverages market to spur its growth. However, the federal legalization of cannabis in the United States is still some time away. With the company scheduled to release its earnings on…

StockNews.com

Dow Jones Falls As Salesforce Pops; Marijuana Stocks Rocket; Tesla Up Despite Elon Musk Probe

The Dow Jones fell as Salesforce stock popped. Marijuana stocks got higher on a government move. Tesla stock fell amid an Elon Musk probe.

Investors Business Daily

Tilray Brands (TLRY) vs. Novo Nordisk (NVO): Which Pharma Stock Should You Buy?

The pharmaceutical sector performs relatively well during economic uncertainties due to inelastic demand for its products and services. While prominent players Tilray Brands (TLRY) and Novo Nordisk (NVO) should benefit, which stock is the better buy now? Read more to find out.

StockNews.com

Should You Add Shares of Tilray Brands (TLRY) to Your Portfolio?

Canadian cannabis leader Tilray Brands (TLRY) is bolstering its portfolio through expansions and partnerships. However, the company’s recent $150 million offering of senior notes put pressure on its stock price. Would it be wise to buy the stock now? Let’s look at its financial metrics to answer that….

StockNews.com

Sell the Farm on These 4 Cannabis Stocks

Despite significant growth in recent years driven by increased legalization, the cannabis industry took a hit last year amid economic and industry-wide headwinds, including stubborn supply gluts. Furthermore, the industry will likely remain under pressure this year due to economic challenges. Hence, it could be wise to avoid fundamentally weak…

StockNews.com

Jim Cramer Is Bullish On Cannabis Stocks Ahead Of Midterm Elections: 'I Say Buy Tilray'

Mad Money host Jim Cramer said last week during a Lightning Round segment that now is a good time to invest in Tilray.

Benzinga

Tilray Net Loss Nearly Doubles From Year Ago, But Biden Marijuana Pardons Keep The Stock Up

Canadian marijuana giant Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) reported Friday financial results for the first fiscal quarter ended August 31, 2022, with net revenue of $153.2 million, which compares to revenue of $168.02 million for the same period last year.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022

Benzinga

Tilray's Fiscal 2022 Revenue Grows 22% YoY, Here Are The Details

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) net revenue grew 8% to $153.3 million during the fourth quarter 2022, from $142.2 million in the prior year quarter.

Benzinga

Tilray Goes Through With It: Closes $155M Investment In HEXO, Expects $80M In Shared Savings

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) has closed its acquisition from HT Investments MA LLC (“HTI”) of the secured convertible note issued by HEXO Corp. (NASDAQ: HEXO

Benzinga

Verizon And 2 Other Stocks Insiders Are Selling

US jobs report for June is scheduled for release at 8:30 a.m. ET. Analysts expect a 270,000 rise for nonfarm payrolls in June, compared with a better-than-expected 390,000 growth in May. Investors, meanwhile, focused on some notable insider trades.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Why Is SCWorx Jumping By Around 36%? 20 Stocks Moving In Wednesday's Pre-Market Session

Gainers Hexo Corp (NYSE: HEXO) rose 106.8% to $0.43 in pre-market trading. HEXO’s shareholders, on Tuesday, approved the note transaction with Tilray Brands.

Benzinga

HEXO Deal Could Be A Big Win For Tilray, This Analyst Tells Us Why

On Wednesday HEXO Corp (NASDAQ: HEXO) reported a staggering loss of CA$152.7 million ($118 million) in the third quarter of 2022, representing a

Benzinga

What 4 Analyst Ratings Have To Say About Tilray Brands

Within the last quarter, Tilray Brands (NASDAQ:TLRY) has observed the following analyst ratings:

Benzinga

HEXO, Tilray Brands Amend Transaction Agreement, Here Are The Details

HEXO Corp. (TSX:HEXO) (NASDAQ: HEXO) has entered into an amending agreement to the transaction agreement with Tilray Brands, Inc. (NASDAQ:

Benzinga

Cannabis On Amazon? Why Tilray Stock Is Trading Higher

Tilray Brands Inc (NASDAQ: TLRY) shares are trading higher Thursday after the company announced the launch of its CBD lifestyle brand POLLEN on the Amazon.com Inc (NASDAQ: AMZN) UK platform.

Benzinga

Tilray Launches New CBD Lifestyle Brand, POLLEN Gummies & Drink Drops Available On Amazon UK

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced the launch of POLLEN, a CBD lifestyle brand with a new approach to wellness, on Amazon UK.

Benzinga

This Analyst Has Mixed Feelings About Tilray's Promise To Achieve $4B In Revenue By 2024, Here's Why

Tilray Brands' (NASDAQ: TLRY) stock has plunged nearly 30% year-to-date.

1 2

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.